Drug Safety Institute

  • Brand Institute, Inc.
  •  
  •  
  • |
  •  
  •  
  • Become a PanelMember
  • Home
  • About Us
    • Jerry Phillips
    • Sophia Fuerst
    • Nora Roselle
  • Our Services
  • Experience
  • Contact Us
Welcome

Welcome to DSI

Drug Safety Institute, a subsidiary of Brand Institute, provides proprietary and nonproprietary name safety testing, risk management strategies, and regulatory submission guidance for pharmaceutical, biotechnology, and healthcare device manufacturers.

In addition, Drug Safety Institute provides medication error prevention analysis for new product labels and packaging.

Services

Our Services

  • Name Safety Research
  • Consults and Rebuttals
  • Failure Mode and Effects Analysis
  • Gap Analysis
  • Name Safety Reports / Submission
  • Nonproprietary Name Research
  • Labeling & Packaging Research
  • Promotional / Advertising Research
  • Risk Management Plans
  • Submission Strategy
Contact Us

Contact Us

Phone: (305) 374-7233

Fax: (305) 374-2504

Email: info@DrugSafetyInstitute.com

  • Latest Newsletter

    • August 2010
      Computerized Handwriting Analysis
    • July 2010
      DSI @ FDA Meeting
    • July 2010
      Wall Street Journal Article
    • June 2010
      Recent Brand Approvals
    • June 2010
      INN Submission Date
  • Recent Related News

    The next Consultation of the International Nonproprietary Names (INN) Committee of the World Health Organization will be held November 16-18, 2010. All INN submissions to be discussed at this meeting must be received by the World Health Organization no later than Monday, September 8th, 2010.

    • See How We Can Help

      Contact Us
  • Contact Information

    200 S.E. 1st Street - 12th Floor
    Miami, FL 33131

    Phone: (305) 374-7233
    Fax: (305) 374-2504
    Email: info@DrugSafetyInstitute.com

    Drug Safety Institute is a Subsidiary of

© 2010 Drug Safety Institute, Inc. • A Subsidiary of Brand Institute, Inc.